Search research articles
Contact Us
Filters
Showing results (1-10 of 96) with videos related to
Page
of 10
Sort By:
Expert Review of Respiratory Medicine
|
August 23, 2014
Ivacaftor for patients with cystic fibrosis
Claire E Wainwright
Presse Medicale (Paris, France : 1983)
|
May 31, 2017
New treatments targeting the basic defects in cystic fibrosis
Isabelle Fajac, Claire E Wainwright
Expert Review of Respiratory Medicine
|
June 23, 2016
Diagnosis and early life risk factors for bronchiectasis in cystic fibrosis: a review
Peter D Sly, Claire E Wainwright
Pathology
|
October 1, 2005
Sensitivity of respiratory bacteria to lignocaine
Snehal S Chandan, Joan Faoagali, Claire E Wainwright
The Cochrane Database of Systematic Reviews
|
May 3, 2024
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis
Kamini Jain, Claire E Wainwright, Alan R Smyth
The Medical Journal of Australia
|
February 5, 2008
Clinical outcomes of Queensland children with cystic fibrosis: a comparison between tertiary centre and outreach services
Clare L Thomas, Peter K O'Rourke, Claire E Wainwright
Oecologia
|
July 14, 2019
Looks can be deceiving: ecologically similar exotics have different impacts on a native competitor
Claire E Wainwright, Robert D Holt, Margaret M Mayfield
The Medical Journal of Australia
|
February 17, 2017
Targeted therapy for chronic respiratory disease: a new paradigm
Peter G Gibson, Matthew J Peters, Claire E Wainwright
Thorax
|
October 3, 2018
<i>Aspergillus</i> and progression of lung disease in children with cystic fibrosis
Sabariah Noor Harun, Claire E Wainwright, Keith Grimwood, et al.
Seminars in Respiratory and Critical Care Medicine
|
January 17, 2023
Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators
Andrew Burke, Rachel M Thomson, Claire E Wainwright, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 96) with videos related to
Sort By:
Page
of 10
Expert Review of Respiratory Medicine
|
August 23, 2014
Ivacaftor for patients with cystic fibrosis
Claire E Wainwright
Presse Medicale (Paris, France : 1983)
|
May 31, 2017
New treatments targeting the basic defects in cystic fibrosis
Isabelle Fajac, Claire E Wainwright
Expert Review of Respiratory Medicine
|
June 23, 2016
Diagnosis and early life risk factors for bronchiectasis in cystic fibrosis: a review
Peter D Sly, Claire E Wainwright
Pathology
|
October 1, 2005
Sensitivity of respiratory bacteria to lignocaine
Snehal S Chandan, Joan Faoagali, Claire E Wainwright
The Cochrane Database of Systematic Reviews
|
May 3, 2024
Bronchoscopy-guided antimicrobial therapy for cystic fibrosis
Kamini Jain, Claire E Wainwright, Alan R Smyth
The Medical Journal of Australia
|
February 5, 2008
Clinical outcomes of Queensland children with cystic fibrosis: a comparison between tertiary centre and outreach services
Clare L Thomas, Peter K O'Rourke, Claire E Wainwright
Oecologia
|
July 14, 2019
Looks can be deceiving: ecologically similar exotics have different impacts on a native competitor
Claire E Wainwright, Robert D Holt, Margaret M Mayfield
The Medical Journal of Australia
|
February 17, 2017
Targeted therapy for chronic respiratory disease: a new paradigm
Peter G Gibson, Matthew J Peters, Claire E Wainwright
Thorax
|
October 3, 2018
<i>Aspergillus</i> and progression of lung disease in children with cystic fibrosis
Sabariah Noor Harun, Claire E Wainwright, Keith Grimwood, et al.
Seminars in Respiratory and Critical Care Medicine
|
January 17, 2023
Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators
Andrew Burke, Rachel M Thomson, Claire E Wainwright, et al.
Page
of 10